Heart Failure Management System

The impact of utilizing the ZOLL® Heart Failure Management System* (HFMS) for fluid management following an acute decompensation event was demonstrated in the Benefits of MicroCor in Ambulatory Decompensated Heart Failure (BMAD) Trial.input:
output:Improved Outcomes and Early Detection of Pulmonary Fluidinput:
output:Pulmonary fluid can accumulate days prior to the onset of symptoms and may serve as an early indicator of a heart failure decompensation event.The Operation of ZOLL HFMS
ZOLL HFMS is a patch-based, non-invasive device that employs innovative radiofrequency technology to detect changes in pulmonary fluid levels in an early stage of heart failure decompensation. An increase in pulmonary fluid levels is a reliable indicator of this condition.input:
output:Interstitial edema, an early indicator of heart failure, can be quantified using radar waves.

Fluid changes are indicated by fluctuations in signal path delay and strength. The Thoracic Fluid Index (TFI) is a highly sensitive and robust measurement that is produced by the highly modulated waves caused by tissue hydration.Additional patient data that can be utilized to inform care plans, such as heart rate, respiration rate, activity, posture, and heart rhythm (ECG), is also recorded, stored, and transmitted by ZOLL HFMS.